Monocytes are a distinct subset of myeloid cells with diverse functions in early inflammatory immune modulation. While previous studies have surveyed the role of microRNA regulation on different myeloid cell lines and primary cultures, the time-dependent kinetics of inflammatory stimulation on miRNA expression and the relationship between miRNA-to-target-RNA expression have not been comprehensively profiled in monocytes. In this study, we use next-generation sequencing and RT-PCR assays to analyze the non-coding small RNA transcriptome of unstimulated and lipopolysaccharide (LPS)-stimulated monocytes at 6 and 24 hours. We identified a miRNA signature consisting of five mature miRNAs (hsa-mir-146a, hsa-mir-155, hsa-mir-9, hsa-mir-147b, and hsa-mir-193a) upregulated by LPS-stimulated monocytes after 6 hours and found that most miRNAs were also upregulated after 24 hours of stimulation. Only one miRNA gene was downregulated and no other small RNAs were found dysregulated in monocytes after LPS treatment. In addition, novel tRNA-derived fragments were also discovered in monocytes, although none showed significant changes upon LPS stimulation. Interrogation of validated miRNA targets by transcriptomic analysis revealed that the majority of differential mRNA expression was maintained in LPSstimulated monocytes although few of miRNA targets seemed to obtain heterogeneous expression pattern along the treatment. Our findings reveal a potential role by which selective miRNA upregulation and stable expression of other small RNAs enable monocytes to develop finely tuned cellular responses during acute inflammation.
Monocytes belong to a subset of circulating white blood cells that can further differentiate into macrophages and dendritic cells in solid tissues surrounding sites of injury [1] . In vivo and in vitro studies have shown that monocytes and their derivatives function as an essential component of the innate immune system that mediate the host defense, serve as the first line of resistance to microbial attack, modulate tumor-associated immune defense responses, and regulate tissue homeostasis [2] . Indeed, the pleiotropic potential of monocytes suggests that their cellular functions must be tightly regulated in a manner unique from more differentiated myeloid cell types to enable appropriate, context-dependent responses.
Micro-RNAs (miRNAs) are a large class of small noncoding RNAs that post-transcriptionally regulate mRNAs and subsequently influence essential cellular functions through modulation of gene expression at the RNA or protein level [3] . miRNAs are initially transcribed as long primary transcripts (pri-miRNA) by mammalian type II RNA polymerases and then processed into precursor hairpin intermediates (pre-miRNA) in cell nuclei by an RNase III (Drosha). After transport to cytoplasm by an export complex, Exportin5-RanGTP, pre-miRNAs are further processed by another cytoplasmic RNase III, Dicer, to generate 18-24 nucleotide mature miRNAs through a highly regulated biogenesis process [4] . Mature miRNAs are then loaded into the RNA induced silencing complex (RISC) which targets specific mRNA causing translational repression or degradation of the targeted mRNAs [5] . Each miRNA can potentially target dozens to hundreds of mRNAs, and, thus, miRNAs have been implicated in regulating multiple and disparate biological pathways [4] [5] [6] .
Several miRNAs in myeloid cells have previously been identified that impact immune responses, although results have varied due to different cell types, assay methods, and culture/stimulation conditions [7, 8] (summarized in Supplementary Table 1) . Expression analyses using oligo-based microarray technology revealed that hsa-mir-155 was highly induced during the maturation of dendritic cells derived from human monocytes and in monocyte cell lines [9, 10] . This finding was further confirmed with the identification of other miRNAs, including hsa-mir-9 and hsamir-146a, which were up-regulated in LPS-treated monocytes using a qPCR-based platform [11] . In each study, however, a genome-wide assessment of small RNA expression profiles was limited due to the use of oligo-based or qPCR-based assay platforms. Next-generation sequencing (NGS) technologies have significantly increased the ability to detect low abundant and novel small RNAs in numerous human cell types [12] [13] [14] . This method enables the isolation and detection of all small
RNAs without a priori knowledge or bias, allowing for global expression profiling of small RNAs relevant to activated monocytes. Such analyses have also led to the discovery of small RNA species other than miRNAs that include RNA fragments derived from small nucleolar RNA (snoRNA) and transfer RNA (tRNA) [15] . While the function of these snoRNA-derived (sdRNA) and tRNA-derived (tRF) RNAs is obscure, their expression is altered in certain human diseases [15] [16] [17] . Further analyses of the functional role of smRNAs and tRFs may lead to the development of disease-associated biomarkers or avenues for novel therapeutic strategies.
In this study, we performed deep sequencing to interrogate the expression of small RNAs in non-stimulated and LPS-stimulated human monocytes from multiple donors. The small RNA transcriptome mainly consisted of miRNAs but also contained snoRNAs, rRNAs, Y RNAs, and tRNAs.
We find that a small set of miRNAs are stably upregulated following LPS stimulation at two different timepoints and confirm these findings using multiple RT-PCR assays. We also examine how miRNA upregulation affects target mRNA levels by analyzing the RNA expression of stimulated monocytes using RNA-seq. Furthermore, we describe, for the first time, identification of 18 tRNA-derived fragment RNAs in monocytes. Further analyses of these identified small RNAs may lead to a better understanding of their role in monocyte biology and serve as biomarkers to detect monocyte function in human disease.
MATERIAL AND METHODS

Preparation and lipopolysaccharide (LPS) treatment of human monocytes
Ethics Statement: Samples were collected anonymously through an internal blood donor program that was monitored by the Western IRB Board and was considered exempt from IRB approval.
Primary human monocytes were freshly isolated from peripheral blood mononuclear cells (PBMCs) from individual donors using the EasySep Monocyte Enrichment kit from Stem Cell Technologies (negative selection). Cells underwent analysis by flow cytometry for purity (CD14-PE) (Becton Dickerson), with donor preps having cell purity greater than 90% for deep sequencing and further validation. Monocytes were suspended at 10 million/ml in X-Vivo medium (Lonza) supplemented with 5% AB human serum (Invitrogen) and incubated for 6 or 24 hours with either medium only or with media containing 100 ng/ml lipopolysaccharide (InVivoGen). All cells (both adherent and suspension) were harvested, washed, and pelleted, with the cell pellet snap-frozen on dry ice and placed at -80 o C until further analysis.
RNA isolation
Cell pellets containing 10-20 million monocytes each were lysed and homogenized in 1ml of the Trizol reagent from Life Technologies. Following commercial instructions, sedimentation of the aqueous and organic phases was carried out by vigorous shaking after adding 0.2 ml chloroform and subsequent centrifugation of the samples at 14,000 RPM for 20 minutes using a bench top centrifuge (Eppendorf). The aqueous phase was carefully transferred to a new 1.5ml tube and then mixed with 0.45 ml of 100% isopropanol. The RNA was centrifuged and precipitated at 14,000 RPM for 20 minutes. After washing with 75% ethanol, the RNA was dissolved in DEPC-treated water and its quality and concentration were determined using Bioanalyzer (Agilent) and Nanodrop (Thermo Scientific), respectively.
Small RNA library Construction
Barcoded cDNA Libraries were generated from 1ug of total RNA from each human monocyte sample using the Illumina TruSeq small RNA kit per the manufacturer's protocol. The small RNA libraries were further purified by electrophoresis in a 6% PAGE gel. After extraction from the gel slices between 140-160 bp, the libraries were concentrated by ethanol precipitation. cDNA libraries were suspended in 10mM Tris, pH 8.0 buffer and the DNA concentration was determined using
Taqman-based qPCR assay.
Deep sequencing and data analysis of small RNA libraries by Illumina NGS Approximately 1.2 pmol of small RNA libraries were pooled and sequenced using either a HiSeq or GA flowcell. Clusters were generated using an Illumina C-BOT instrument. One multiplexing single read, 30/7, was set up and performed on the Illumina HiSeq 2500 or Illumina GAIIx using the small RNA sequencing kit. Once FASTQ files were generated from raw BCL output, the total reads of each library were batched into individual bins based on sample barcode indices. The adaptor sequencing was stripped from each read, and reads without the 3′ adaptor sequence were filtered out. Reads with low quality (Phred Q<30) or length ≤12 nt after adaptor stripping were further removed. For the remaining high-quality reads, we counted the occurrence of each unique sequence in each sample and compressed the read files to contain only unique sequences. Unique reads were then aligned to small RNA reference library using the OmicSoft Aligner (V5.1) [18] . The small RNA reference library includes: miRNA hairpin sequences from miRBase (v20) [19] , tRNA sequences from GtRNAdb [20, 21] , snoRNA/scaRNA sequences from snoRNABase [22] , rRNA and Y RNA 1/3/4/5 from NCBI. After mapping, reads that aligned to a unique reference sequence were retained, and read abundances were normalized to counts per million (CPM). DESeq2 [23] was used to test for differential expression of small RNAs, controlling for the effect of the donor on normalized expression (i.e. design ~ donor + LPS.treatment).
Expression Validation by Taqman-based qRT-PCR assays 1 ug of total RNA was treated with DNase 1 (New England Biolabs) in 50 ul 1x DNase1 Buffer as outlined in the commercial protocol. All the miRNA-specific and U6 Taqman-based assays and reagents were acquired from the commercial collection at ABI/Life Technologies. After reverse transcription with the primers specific for individual miRNAs that were provided in the assays, the transcribed cDNA was applied for quantification by using Taqman-based assays on ABI 7900HT. This was indicated as the relative expression to the level of U6 RNA according to Ct that was calculated and generated using the ABI SDS version 2.4 software after normalization of RNA input.
Tagged RT-PCR Semi-Quantification for mature and precursor miRNAs 1 ug of DNase1-treated total RNA was then heated to 70°C for 2 minutes to eliminate secondary structure, and immediately cooled on ice. The 5' and then the 3' adapters were ligated to the sample using the miRCat33 (Integrated DNA Technologies; IDT) in subsequent reactions with a sodium acetate clean-up between each reaction as outlined in the protocol. These reactions were followed by reverse transcriptase using Invitrogen Superscript III, and then diluted 4x with IDTE (pH 7.5) supplied in the miRCaT33 Kit. The primers that were reversed and complimentary to the miRNA specific sequences were designed and ordered from IDT. These primers coupled with the miRCAT forward or reverse primers (depending on the orientation of the miRNA sequence on the precursor miRNA) were included in a PCR reaction using Promega GoTaq® Hot Start Green Master Mix.
Optimum cycles varied per miRNA based on the level of expression, typically starting at 25 cycles for hsa-mir-155 and hsa-mir-21, 28 cycles for hsa-mir-146a and hsa-mir-147b, and 31 cycles for hsa-mir-9 and hsa-mir-193a by using the following conditions: Table 2 ). An analysis pipeline elucidated in Supplementary Fig 1 was applied for data QC, read alignment, and small RNA transcriptome analysis. Individual sequences were aligned to a miRNA hairpin sequence database from miRBase and other small RNA reference databases (tRNA sequences from GtRNAdb; snoRNA/scaRNA sequences from snoRNABase;
ribosomal RNAs and hY RNAs 1/3/4/5 from NCBI) using the OmicSoft Aligner.
An average of 54.0% of the unique reads that passed the QC metrics mapped uniquely to one of the small RNA references listed above (Supplementary Table 2 ). 72.1-95.8% of the mapped reads were specifically categorized to miRNA ( Supplementary Fig 2) , which spanned 20 to 24 bp in sequence length ( Supplementary Fig 3) . Among the 1,859 miRNA sequences listed in miRBase, 451
were detected in all samples while 850 miRNAs were detected in over half of the samples. While expression of miRNAs spanned five orders of magnitude, the top 100 expressed miRNAs comprised 92% of the entire miRNA population detected in human monocytes, revealing that miRNA gene diversity is largely restricted to the most highly expressed miRNAs (Supplementary Fig 4) . The remainder of the mapped reads aligned to rRNAs (2.8-15.4%), snoRNAs (0.60-13.7%), tRNA (0.23-1.2%), and hY RNAs (0.41-7.3%) ( Supplementary Fig 2) .
miRNA transcriptome analysis in human LPS-treated monocytes
To determine whether monocytes stimulated by LPS differentially express miRNAs relative to monocytes cultured only in medium, we performed differential expression testing between monocytes that were cultured for the same duration using DESeq2, adjusting for patient-specific effects and using normalized read counts. We found that 15 and 13 miRNAs are differentially expressed between LPS-and medium-treated monocytes at 6 and 24 hours, respectively, after correcting for multiple testing (adjusted p-value < 0.05, FDR=0.01) ( Tables 1 and 2 ) (Fig 1A-1B) . At 6 hours, all 15 miRNAs were upregulated with 1.7 -11.2-fold upregulation (Fig 1A) . At 24 hours, the magnitude of upregulation was more pronounced relative to the monocytes stimulated for 6 hours, with 12 out of the 13 miRNAs having 2.3 -55.3-fold upregulation ( Fig 1B) . One miRNA, hsa-mir-7151 was downregulated in monocytes stimulated with LPS for 24 hours. Five miRNA species (hsa-mir-155, hsa-mir-146a, hsa-mir-9, hsa-mir-147b, hsa-mir-365b and hsa-mir-193a) were upregulated at both timepoints from the NGS data and may serve as steady regulators of the inflammatory response of monocytes. Of the stably upregulated miRNAs, only hsa-mir-155 and hsa-mir-146a were among the top 100 most highly expressed miRNAs ( Supplementary Fig 4) . Examination of each donor sample sequenced revealed high patient-to-patient variability in baseline expression of each miRNA, as the miRNA expression level in media-treated monocytes of some patients exceeded the expression level in LPS-treated monocytes of other patients (Fig 1C-1D ). However, intra-patient differential miRNA expression was consistent after LPS stimulation for all differentially expressed miRNAs, underscoring the importance of correcting for patient variance and revealing that relative miRNA changes rather than absolute miRNA levels may be more important for the induction of monocyte responses to inflammatory stimuli.
Expression Validation of mature miRNAs by quantitative RT-PCR and pre-cursor miRNAs by tagged RT-PCR
To confirm upregulation of signature miRNAs that were observed by NGS in LPS-stimulated human monocytes, we utilized quantitative real-time PCR to analyze the expression patterns of miRNAs upregulated at both timepoints, one of the timepoints, and at neither timepoint. Of the miRNAs upregulated at both timepoints by NGS, we confirmed upregulation of hsa-mir-155, hsa-mir-146a, hsa-mir-9, and hsa-mir-147b (Fig 2A-2D ). (Hsa-mir-9-1 and hsa-mir-9-2 both produce the same mature miRNA (hsa-mir-9) and are detected in the same RT-PCR reaction.) RT-qPCR also identified upregulation at 24 hours but not after 6 hours for hsa-mir-187, hsa-mir-193a, hsa-mir-99b, hsa-mir-125-5p, or hsa-mir-125-3p (Fig 2E-2I ). This corroborated NGS results for all miRNAs except for hsamir-193a, which originally had shown the most modest upregulation (1.7-fold) out of the upregulated miRNAs in the NGS data ( Fig 1A) . Hsa-mir-365b showed upregulation at neither timepoint by qRT-PCR ( Fig 2J) . Hsa-mir-146b, hsa-mir-149, and hsa-mir-2116 were also included as negative controls for qRT-PCR based on NGS results. Hsa-mir-146b, which was previously identified in another study [11] , was selected as a negative control since it differs from hsa-mir-146a by two nucleotides. Hsa-mir-449c, hsa-mir-149, and hsa-mir-2116 showed similar expression in both treatment groups. Importantly, none of the miRNAs selected as negative controls were differentially expressed by RT-qPCR (Fig 2J-2M ). Overall, RT-qPCR confirmed time-dependent miRNA expression patterns for 25 of the 28 conditions tested across 14 miRNAs (hsa-mir-193a ( Fig 2F) and hsa-mir365b ( Fig 2N) were the only miRNAs with discrepancies), demonstrating high concordance between the two methods. In correlation with the NGS results, upregulated miRNAs detected by qRT-PCR generally tended to have greater relative expression difference in LPS-stimulated monocytes at 24 hours compared to 6 hours.
To determine whether miRNAs were upregulated due to increased transcription of primiRNAs or due to increased pre-miRNA processing by Dicer, we tested whether we could detect upregulation of pre-cursor miRNAs in the miRNAs upregulated by LPS stimulation after 6 hours. We developed a semi-quantitative RT-PCR method to simultaneously visualize the differential expression of both mature and precursor forms of miRNA based on the differences in amplicon size. As detailed in Figure 3A , we introduced linker RNA oligos at both ends of RNA transcripts and followed this by
RT-PCR with a pair of oligos located on a universal linker sequence and a miRNA-specific region.
Amplified products were then resolved by gel electrophoresis, enabling separation of the smaller mature miRNA products separated from larger pre-cursor miRNA products. The assay revealed that expression of both mature and precursor forms of hsa-mir-155, has-mir-146a, and has-mir-193a
were robustly induced in LPS-treated human monocytes ( Fig 3B) . This revealed that increased transcription of these pri-miRNAs contributed to their upregulation. LPS upregulation of the mature forms of hsa-mir-9 and hsa-mir-147b could be easily detected, but we only visualized trace amounts of their precursors (Fig 3B) . Such upregulation of has-mir-9-1 precursor, which is one of pri-miRNA for production of mature has-mir-9, was further confirmed by using the qRT-PCR assay (Table 3) .
Hsa-mir-21 expression, which were expressed abundantly in all NGS samples and served as a positive control for expressed small RNAs in human monocytes, showed even expression in mature and precursor forms regardless of LPS stimulation (Fig 3B) .
Overall, using a combination of small RNA-sequencing, qPCR, and RT-PCR, we identified a signature of five mature miRNAs (hsa-mir-155, hsa-mir-146a, hsa-mir-9, hsa-mir-193a, and hsa-mir147b) whose upregulation in LPS-stimulated monocytes were validated by at least two different methods at both 6 hours and 24 hours post-stimulation (Table 3) .
Relationship between upregulated miRNAs and target mRNA expression
Having defined five signature miRNAs that were stably upregulated at 6 and 24 hours after stimulation, we next investigated how upregulation of these miRNA species affects the differential expression of target mRNA genes. We performed RNA-sequencing of 12 samples (6 LPS-treated, 6
media-treated) from 6 donors stimulated with LPS for 6 hours. We also performed RNA-sequencing of 6 samples (3 LPS-treated, 3 media-treated) from 3 donors stimulated with LPS for 24 hours. Reads were aligned to the human genome (build hg38) and DESeq2 was used to test for differential expression. In total, 734 differentially expressed genes were identified at 6 hours (462 upregulated, 272 downregulated) (Table 4 ) and 588 DEGs were identified at 24 hours (516 upregulated, 72 downregulated) (Table 5 ). 1270 unique genes were differentially expressed in total, with 52 of those genes shared at both timepoints. Principal components analysis (PCA) of all differentially expressed genes revealed that samples treated with LPS clearly clustered separately from unstimulated samples, as explained by principal component 1 (Fig 4A-B) . To a lesser extent, samples treated for 6 and 24 hours also clustered separately from each other (Fig 4A-B) . The differences in differentially expressed genes and global expression profiles as analysed by PCA reveal that mRNA expression in monocytes varies highly between 6 and 24 hours even though the miRNA expression profile remains relatively similar.
Analysis of gene ontology (GO) terms associated with the differentially expressed genes identified response to LPS, response to molecule of bacterial origin, and response to IL-1 as primarily cell functions associated with LPS stimulation at 6 hours ( Supplementary Fig 5) . Conversely, GO terms plasma lipoprotein particle clearance, regulation of phospholipase A2 activity, and positive regulation of myeloid cell differentiation were most significantly enriched in the genes associated
with LPS downregulation at 6 hours ( Supplementary Fig 5) . At the 24-hour timepoint, GO terms cell migration and locomotion were associated with genes enriched by LPS stimulation, while GO terms regulation of innate immune response and humoral immune response were associated with genes downregulated by LPS stimulation (Supplementary Fig 5) .
We first identified differentially expressed genes that were also functionally validated miRNA targets by miRTarBase and asked how expression of these genes varied between monocytes treated with and without LPS. At 6 hours, we identified 28 such genes (Fig 4C) . Surprisingly, we found that only 7 genes (all of which are regulated by hsa-mir-155, except TGFBI and HMGB1, which are regulated by hsa-mir-9 and hsa-mir-193a, respectively) were downregulated in LPS-stimulated monocytes, while the remaining 21 genes were upregulated in LPS-stimulated monocytes. Four genes were regulated by multiple signature miRNAs (Fig 4C) . At 24 hours, we identified 15 differentially expressed genes that are also known targets for the upregulated miRNAs, of which two genes were regulated by multiple signature miRNAs ( Fig 4D) . All 15 genes were upregulated in LPSstimulated monocytes, indicating a consistent pattern of gene upregulation in LPS-treated monocytes despite concurrent upregulation of miRNAs.
We also determined whether miRNA upregulation might result in lower target mRNA expression over time. Using MirTarBase, we first compiled a list of functionally validated miRNA targets genes of hsa-mir-155, hsa-mir-146a, hsa-mir-193a, hsa-mir-9, and hsa-mir-147b. Then we analysed their fold-change in expression relative to LPS at both 6 and 24 hours (Fig 5A) . We identified a heterogenous pattern of target RNA expression, as some target mRNAs (e.g. IL6, TNF) had greater relative expression at 6 hours than after 24 hours, while other mRNAs (e.g. IRAK3, NFKB1) had greater relative expression after 24 hours. A slight majority of miRNA-regulated genes had greater relative expression at 24 hours relative to at 6 hours despite consistent miRNA expression at both time points (Fig 5B-F) . The upregulation of these genes suggests that despite the consistency of miRNA upregulation in response to acute LPS stimulation, other factors besides miRNA likely play a major role in regulating RNA expression. The results also suggest that miRNAs in LPS-stimulated monocytes do not completely abrogate mRNA expression but may fine-tune mRNA expression to so that cellular responses can be enacted with precision.
Identification of tRF RNAs derived from transfer RNA in human monocytes
In addition to the miRNAs sequences we characterized, a significant portion of the NGS reads were mapped to other small RNA species with known functions in altering cellular function.
While we did not detect significant differential expression in any of the small RNA species after LPS stimulation ( Supplementary Figs 6 and 7) , we investigated whether any tRNA-derived fragment (tRF)
RNAs were conserved in human monocytes. tRFs are derived from transfer RNAs, and several species have been cloned and identified in few organisms and cell types [16, 17] . To investigate tRF RNAs in human monocytes throughout the genome, we mapped all the small RNA sequence reads systematically to the tRNA genomic database. We compared 30 bp of the flanking regions upstream or downstream to all of the 625 known or predicted tRNA gene loci that resulted from the predictions of the program tRNAscan-SE [20, 21] . By screening the sequencing reads along with these tRNA regions, we generated a collection of the sequences that were 20-30 bp in size, appeared at least 500 counts per million reads and presented at least 100 times more than the 2 nd highest sequence in the same tRNA gene locus. This enabled us to identify stable tRF sequences that were frequently generated in monocytes after RNase Z or Dicer processing in the gene silencing complex.
The enrichment threshold served to prevent detection of tRNA pieces that resulted from random degradation. Our screening strategy identified 18 tRF conserved sequences in human monocytes.
These 18 tRFS could potentially be derived from a list of 50 tRNA loci that encoded 18 types of tRNA for 12 specific amino acids. Of these 18 tRFs, 7 were mapped to the 5'-end, 8 were located on the 3'-end, 1 was located in the middle, and 2 were found at the 3' downstream of tRNA genes (Table 6 ).
Lee et al. identified 17 tRFs in human prostate cancer cell lines, including 5 at the 5'-end, 8 at the 3'-end, and 4 in the downstream of the tRNA genes [24] . Three of them, tRF-1001 (tRF-SerTGA), tRF-3006 (tRF-GlyGCC), and tRF-5005 (tRF-GlyGCC), were also found in the list of our human monocyte samples. The other 15 tRFS in our study are novel.
DISCUSSION
In this study, we carried out a comprehensive small RNA transcriptome analysis in human monocytes from multiple donors and investigated how monocytes utilize miRNAs to regulate their response to over time during acute inflammation induced by LPS. Using NGS enabled us to globally profile all small miRNAs in an unbiased manner, allowing us to validate new miRNAs and filter out low quality sequences that are likely to be false positives. Based on the frequency of the sequencing reads mapped to human genome, we found that 72.1-95.8% of the sequencing reads were mapped to miRNAs followed by the reads mapped to rRNAs, snoRNAs, tRNAs, and hY RNAs, suggesting that miRNAs are the predominant class of small RNA species from 18-nt to 30-nt in length. The analysis also revealed disproportionate miRNA expression in monocytes, as the top hundred species of miRNAs accounted for over 90% of the miRNA population in human monocytes although over eighteen hundred miRNAs have been published in miRBase. We also identify 18 tRFs that have not been previously described in monocytes, and future studies investigating these genes will elucidate their cellular functions in monocytes. In addition to discovering miRNAs that are uniquely upregulated at 6 hours and 24 hours post-stimulation, we identified a signature of five miRNAs that were stably upregulated at both phases of inflammation. This concise list of signature miRNAs suggests that monocytes selectively activate only a few miRNA species rather than respond with a universal shift in all miRNA populations within the short-term response to LPS stimulation.
Previous investigations have used oligo-or qPCR-based arrays to identify miRNAs in myeloid cells that rapidly increase expression through activation of TLRs or TNFSupplementary Table 1 ).
Most of these studies have focused on myeloid cell lines or macrophages, which differ in their gene regulation circuitry. As a result, LPS stimulation may cause slightly different miRNAs to be enriched in each cell type (Supplementary Table 1 ) even before accounting for differences in dosage and length of stimulation. This illustrates the importance of considering cell type, species of origin, and treatment duration when understanding miRNA expression.
Despite differences in cell type, classic miRNAs hsa-mir-155 and hsa-mir-146 were consistently implicated in nearly all previous investigations including our study, suggesting that these miRNAs are critical for promoting pan-myeloid function in response to LPS [9, 10, 25] . Moreover, since monocytes act as first responders to inflammation and can differentiate into macrophages and dendritic cells, the upregulation of both miRNAs suggests that different stages of the innate myeloid response share some similar regulatory mechanisms. Hsa-mir-155 had been demonstrated to be involved in differentiation/proliferation of B-cells, cancers, cardiovascular disease, apoptosis, and viral infection previously [25] . Its direct targets include genes involved in transcription regulation, membrane receptors, kinases, binding proteins, and nuclear proteins [26] . hsa-mir-155 was also shown to directly target some of the genes involved in tumor suppression and apoptosis, including
FAs-associated via death domain (FADD), Jumonji AT-rich interactive domain 2 (JARID2), and Src homology 2-containing inositol phosphatase-1 (SHIP1) [26] and, also, suppressed Caspase 1 (CASP1) in dendritic cells [9] and tumor protein 53-induced nuclear protein 1 (TP53INP1) in pancreatic tumors [27] . The findings supported that hsa-mir-155 may be implicated in anti-apoptosis or cell survival besides activation of the innate immune response. Hsa-mir-146a has been reported to modulate inflammatory responses in human CD14 + CD16 -monocytes by inhibiting NF-kB [28] .
Another study investigating hsa-mir-146a control of NF-kB activity also found that hsa-mir-146a
significantly decreases IRAK1 and TRAF6 levels [29] . Both hsa-mir-155 and hsa-mir-146a inhibit key signalling mediators of the TLR pathway and inflammatory response. Our results not only confirm these findings but demonstrate that they maintain consistent upregulation even 24 hours after LPS stimulation. According to the result generated by the tagged RT-PCR assays, which can detect specific miRNA sequences at all stages of cytoplasmic miRNA biogenesis, both mature and precursor hsa-mir-155 or hsa-mir-146 were robustly induced in LPS-treated human monocytes. This reveals that activation of these classic miRNAs occurs before the precursor miRNAs are processed, likely through transcriptional activation in the cell nucleus.
Hsa-mir-9, hsa-mir-147b, and hsa-mir-193a appear to be more specific to monocytes than to macrophages and other monocyte derivatives [9] [10] [11] [30] [31] [32] [33] [34] [35] [36] . A previous study used Taqman Low Density Arrays to study miRNAs in human monocytes and identified hsa-mir-9 in monocytes stimulated by LPS for up to 8 hours [11] . Hsa-mir-9, like hsa-mir-146a and hsa-mir-155, also directly suppresses NFKB, but uniquely interacts with IRAK2, a signalling protein that interacts with TRAF6, MYD88, and Mal to induce TLR4-mediated NFBB activation [35] . Although there is no previously published literature related to hsa-mir-147b in human monocytes, murine mir-147, a murine analogue of hsa-mir-147b, was reported to be induced after the stimulation of Toll-like receptors.
This induction occurred though TLR4 by LPS in mouse macrophages and negatively regulated TLRassociated signalling through the suppression of IL-6 or TNFto prevent excessive macrophage inflammatory responses [32] . Future studies will investigate whether hsa-mir-147b also prevents excessive monocyte-mediated inflammation and proliferation in humans. Hsa-mir-193a, has been reported in multiple organs to act as a tumor suppressor [36] . Although its upregulation has not been previously reported in human monocytes, its ability to bind DNA chaperone Hmgb1, which can bind to TLR4, suggests that hsa-mir-193a may help regulate excessive TLR signalling [37, 38] .
Bazzoni and colleagues also report that hsa-mir-99b, hsa-mir-125a and hsa-mir-187 are induced after 8 hours of LPS treatment [11] , while our study finds that these miRNA genes are upregulated after 24 hours but not after 6 hours of LPS treatment. Two possible reasons may explain why our findings differ slightly from those reported in that study. First, it is possible that these three miRNAs are induced after 8 hours but not after 6 hours of LPS stimulation. Second, RPMI1640, which was used in their study to culture cells, contains glutathione, which may exogenously prime the induction of miRNA genes in response to inflammatory stress, while X-Vivo media used in our study does not contain glutathione [39] . Regardless of the exact timepoint for activation, both studies confirm that these miRNA species become upregulated in response to LPS.
As shown in Table 7 , although multiple TLR signalling pathways can induce the miRNAs we detected, the promoter regions of murine mir-147 and human hsa-mir-155, hsa-mir-146a, and at least one of hsa-mir-9 family members, hsa-mir-9-1, contained the NF-B or AP-1 binding sites that could be responsive to LPS induction and reach maximal level within 8 hours from the activation of NF-B or C-JUN through TLR4 signalling during pro-inflammatory immune response [9] [10] [11] 31, 32, 40, 41] . Several reports related to target identification by performing miRNA-mRNA expression profile pairing, in silico prediction of the target sites, and target validation in vitro revealed that some components or their binding partners in the MyD88-dependent proinflammatory signalling pathway appeared in the direct target list of these miRNAs. IRAK-1 and TRAF6 were the direct targets of both hsa-mir-146a [10] and hsa-mir-147b [32] , and NF-B was directly suppressed by hsa-mir-9 [11] . hsa-mir-155 could directly negatively modulate expression level of IKK, RIPK1, FOS, FADD, as well as TAB2 and Pellino-1 that were parts of theTRAF6 complex in TLR/IL-1 signalling [9, 11, 30] . Although only mild suppression of these targets could be achieved by an individual miRNA, by orchestrating modulation of the key components by different miRNAs in the same cascade, we hypothesize that the subset of signature miRNAs provided monocytes an internal mechanism of actions to maintain the normal physiological function and avoid hyper-reaction of proinflammatory immune response. We propose that they do this by fine-tuning gene expression of the key components in the pathway under the impact of LPS stimulation, while exposing bacterial antigens to macrophages or other antigen presenting cells (Fig 7) . However, this hypothesis does not rule out the other possible functions of these miRNAs in monocytes since dozens of the targets, validated or predicted, were still found outside of TLR/IL-1 or TNF pathways [25, 30, 42] .
We also investigated the impact of upregulated signature miRNAs on target mRNA expression. Although miRNAs post-transcriptionally inhibit target mRNAs and can mediate mRNA degradation in minutes [43] , we find that the overall abundance of target mRNAs depends on the specific gene. For example, while many genes regulated by upregulated miRNAs showed a decrease in overall expression from 6 hours to 24 hours, over 50% of target genes had higher relative abundance after 24 hours relative to 6 hours. This demonstrates the complex relationship between miRNA and mRNA, as the rate of new mRNA transcription and miRNA-mediated decay can oscillate over time. Since numerous other mechanisms, such as transcription factor recruitment, transcription initiation, and P-body activity, all affect mRNA levels, our results suggest that miRNAs play a role in fine-tuning mRNA responses rather than drastically influencing absolute expression levels. Such activities enable cell responses to be rapidly and precisely tuned to exogenous and internal cellular stimuli.
At the end of the study, we identified and reported a subset of small RNAs, tRFs, that were frequently mapped to the distinct portions of several specific tRNAs. Under our screening criteria, 18 tRF conserved sequences were identified according to the public tRNA database. Three of our 18
tRFs were published as tRF-1001 (tRF-SerTGA), tRF-3006 (tRF-GlyGCC), and tRF-5005 (tRF-GlyGCC) by This study was funded and supported by Amgen Inc., which played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.
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